New model reduces opioid prescribing

New model reduces opioid prescribing
A graphic shows IMC high dose opioid vs buprenorphine. Credit: OHSU/David Riofrio

An internal medicine clinic at Oregon Health & Science University has sharply reduced the amount of opioids prescribed though innovative use of a review board comprising a team of health care professionals from various disciplines to ensure patients' needs are being met.

This board advises OHSU primary care and internal medicine providers seeing patients who had been prescribed powerful and addictive pain-killers.

Their experience was published today in the journal Annals of Family Medicine.

"Once we began to discuss these cases, our numbers really began to come down quite steadily," said co-author Mary Pickett, M.D., associate professor of medicine (general internal medicine and geriatrics) in the OHSU School of Medicine.

In 2016, the Centers for Disease Control and Prevention adopted a landmark set of opioid-prescribing guidelines. The guidelines, which happened to be co-authored by Roger Chou, M.D., director of the Pacific Northwest Evidence-based Practice Center at OHSU, were intended to ensure patients have access to safer, more effective chronic pain treatment while reducing the number of people who misuse or overdose from opioids.

OHSU internal medicine clinicians had been focused on safe prescribing well ahead of the CDC guidelines, but starting in 2017, the board began to systematically review high-risk cases in the clinic.

"The question was, how do clinics actually implement those guidelines in practice?" said Jonathan Robbins, M.D., assistant professor of ( and geriatrics) in the OHSU School of Medicine. "The opioid review board was a way to turn high-level recommendations into action steps we can take in our clinic to treat patients and create a culture of safe prescribing."

Patients sign a waiver to have their treatment reviewed by the board, which meets monthly for an hour and comprises several physicians, a clinical pharmacist, a licensed clinical social worker, a medical assistant, a patient access specialist and a medical resident. The clinic started by reviewing treatment of patients being prescribed more than 90 morphine equivalent daily doses, or MEDD.

The clinic used electronic search methods to review a large volume of patient records.

"We combed through 14,000 patients in our clinic and developed a registry about who we're chronically treating with opioids," Pickett said. "We picked out high-risk cases to review and invited those patients' primary care doctors to consult with us."

The group initially identified 664 patients on chronic opioid therapy.

"We're coaching providers to approach this carefully, and, when necessary, slowly taper their patients," Robbins said. "We don't do anything abruptly, and patients have supported this careful process."


Explore further

Researchers find alarming risk for people coming off chronic opioid prescriptions

More information: Jonathan L. Robbins et al, The Implementation of a Clinic-Based Opioid Review Board to Address High-Risk Opioid Prescribing in Primary Care, The Annals of Family Medicine (2021). DOI: 10.1370/afm.2738
Journal information: Annals of Family Medicine

Citation: New model reduces opioid prescribing (2021, November 9) retrieved 25 January 2022 from https://medicalxpress.com/news/2021-11-opioid.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
4 shares

Feedback to editors